| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | Senior Vice President | Common shares without par value | 41,257 | $4,466,895 | $108.27 | 24 Feb 2026 | Direct |
| ABBOTT LABORATORIES | Senior Vice President | Option (right to buy) | 44,821 | 24 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24 Feb 2026 | 2 | $0 | 4 | Senior Vice President | 26 Feb 2026, 19:24 |
| ABT | ABBOTT LABORATORIES | 25 Nov 2025 | 1 | -$203,043 | 4 | Senior Vice President | 25 Nov 2025, 16:17 |
| ABT | ABBOTT LABORATORIES | 03 Mar 2025 | 1 | -$77,652 | 4 | Senior Vice President | 04 Mar 2025, 20:00 |
| ABT | ABBOTT LABORATORIES | 01 Mar 2025 | 0 | $0 | 3 | Senior Vice President | 03 Mar 2025, 20:29 |